Encaleret sulfate

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameEncaleret sulfate
Drug Alias Name硫酸恩卡瑞encaleretumEncaleret恩卡瑞硫酸盐硫酸恩卡来瑞 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium sensing receptor antagonists
TargetsCalcium sensing receptor
Therapy Area/IndicationsAutosomal Dominant Hypocalcemia Type 1HypocalcemiaOsteoporosis, Postmenopausal +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesJapan Tobacco (Hong Kong) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCalcilytix Therapeutics IncBridgebio Pharma IncNational Institute Of Dental And Craniofacial Research (Nidcr)
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsAutosomal Dominant Hypocalcemia Type 1Hypocalcemia
Inactive IndicationsOsteoporosis, PostmenopausalOsteoporosis

Other Information

ATC CodeN/A
Related LinksKEGG